Last reviewed · How we verify

Standard Oxygen

Central Denmark Region · FDA-approved active Small molecule

Oxygen increases the partial pressure of oxygen in the blood and tissues, improving cellular oxygenation and aerobic metabolism.

Oxygen increases the partial pressure of oxygen in the blood and tissues, improving cellular oxygenation and aerobic metabolism. Used for Hypoxemia and respiratory insufficiency, Acute and chronic hypoxic conditions requiring oxygen supplementation.

At a glance

Generic nameStandard Oxygen
Also known asNo SpO₂ target restriction and 100% compressed oxygen as nebulizer driver
SponsorCentral Denmark Region
Drug classMedical gas
ModalitySmall molecule
Therapeutic areaRespiratory / Critical Care
PhaseFDA-approved

Mechanism of action

Standard oxygen therapy delivers supplemental oxygen to patients with hypoxemia or respiratory insufficiency, restoring adequate oxygen saturation in the bloodstream and improving tissue perfusion. This supports aerobic cellular respiration and prevents the complications of hypoxia across multiple organ systems.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: